Загрузка...
Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets
Walking impairment is a clinical hallmark of multiple sclerosis (MS) that has been under-recognized as a therapeutic target for pharmacologic intervention. The development and approval of dalfampridine extended release tablets (dalfampridine-ER; known as prolonged-, modified, or sustained-release fa...
Сохранить в:
| Опубликовано в: : | Degener Neurol Neuromuscul Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065578/ https://ncbi.nlm.nih.gov/pubmed/30890878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S19839 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|